Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to evaluate whether a higher dosage of clopidogrel with aspirin (two doses) will decrease the risk of ischemic complications (cardiac death (CV death), myocardial infarction (MI), stroke) after a percutaneous coronary intervention (PCI).


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Factorial Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00335452
Study type Interventional
Source Sanofi
Contact
Status Completed
Phase Phase 3
Start date June 2006
Completion date September 2009

See also
  Status Clinical Trial Phase
Completed NCT00394680 - Stents, Drug Eluting Stents, and CABG- Financial and Clinical Impact. N/A